Trials / Withdrawn
WithdrawnNCT02005068
Ceftaroline in the Treatment of Bone and Joint Infections
- Status
- Withdrawn
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Orlando Health, Inc. · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a study to evaluate the efficacy of Ceftaroline in the treatment of bone and joint infections.
Detailed description
Study evaluates the efficacy of Ceftaroline 600mg IV every 8 hours for the treatment of acute osteomyelitis and/or infected joints.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ceftaroline | The duration of treatment will vary based on type of infection (acute osteomyelitis or joint infection) and if MRSA positive or negative. |
Timeline
- Start date
- 2013-04-01
- Primary completion
- 2014-07-01
- Completion
- 2014-07-01
- First posted
- 2013-12-09
- Last updated
- 2014-08-07
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02005068. Inclusion in this directory is not an endorsement.